Deutsche Bank Starts Clover Health (CLOV) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St rises as Anthropic's IPO filing sharpens focus on AI trade
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mail
Get Alerts CLOV Hot Sheet
Price: $4.62 +0.43%
Rating Summary:
3 Buy, 4 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 18 | New: 40
Rating Summary:
3 Buy, 4 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 18 | New: 40
Join SI Premium – FREE
Deutsche Bank analyst George Hill initiates coverage on Clover Health (NASDAQ: CLOV) with a Buy rating and a price target of $6.00.
For an analyst ratings summary and ratings history on Clover Health click here. For more ratings news on Clover Health click here.
Shares of Clover Health closed at $4.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 1st Source (SRCE) PT Raised to $92 at KBW After a 'High Quality Result'
- Increasing unusual put option volume: BHP XP ITUB BUG STNE YPF AMKR GGAL EQT
- SLB (SLB) PT Raised to $65 at Piper Sandler
Create E-mail Alert Related Categories
New CoverageRelated Entities
Deutsche Bank, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
